1 Min Read
March 8 (Reuters) - Apricus Biosciences Inc:
* Apricus biosciences announces sale of ex-u.s. Vitaros assets and rights to ferring pharmaceuticals
* Apricus biosciences inc - apricus will retain its vitaros rights in u.s.
* Apricus biosciences inc - remains on track to re-submit vitaros nda to fda in q3 of 2017
* Says ferring has agreed to pay apricus an upfront payment of $11.5 million
* Says ferring has aso agreed to pay apricus up to an additional $700,000 with respect to certain product inventory Source text for Eikon: Further company coverage: